Boston Scientific director Yoshiaki Fujimori will not stand for re-election in 2026
Boston Scientific said director Yoshiaki Fujimori, a board member since July 2016 who chairs the Risk, Science and Technology Committee, will not seek re-election at the 2026 Annual Meeting of Stockholders. He will remain a director and in his committee roles until that meeting, and the company said his decision is not the result of any disagreement. The filing does not name a replacement and says the board will continue to evaluate whether adding directors is in the company's best interest.
Key points
- Yoshiaki Fujimori informed the company on February 2, 2026 that he will not stand for re-election.
- He has served on the board since July 2016 and chairs the Risk, Science and Technology Committee.
- He remains a director until the 2026 Annual Meeting of Stockholders.
- The company states the decision was not the result of any disagreement.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.